The Economics of Diabetes Prevention

被引：37

作者：

Herman, William H. ^{[1
]}

机构：

[1] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2011年 / 95卷 / 02期

关键词：

Diabetes mellitus; Glucose intolerance; Cost of illness; Health utility; Cost-effectiveness; Cost utility; IMPAIRED GLUCOSE-TOLERANCE; QUALITY-OF-LIFE; MEDICAL-CARE COSTS; BODY-MASS INDEX; CARDIOVASCULAR EVENTS; STYLE INTERVENTION; TYPE-2; METFORMIN; RISK; ROSIGLITAZONE;

D O I：

10.1016/j.mcna.2010.11.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In the United States, the costs associated with diabetes mellitus are increasing. Although people with diabetes comprise less than 6% of the US population, approximately 1 in 5 health care dollars is spent caring for people with diabetes. Healthy lifestyle interventions for the general population and intensive lifestyle and medication interventions for high-risk individuals present opportunities for diabetes prevention. This article describes the costs associated with glucose intolerance and diabetes, the effect of glucose intolerance and diabetes on the quality of life, and the cost-effectiveness of screening and primary prevention interventions for diabetes prevention.

引用

页码：373 / +

页数：13

共 43 条

[1] Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community - The YMCA model [J].

Ackermann, Ronald T. ;

Marrero, David G. .

DIABETES EDUCATOR, 2007, 33 (01) :69-+

[2] Influence of BMI on Health-related Quality of Life: Comparison Between an Obese Adult Cohort and Age-matched Population Norms [J].

Anandacoomarasamy, Ananthila ;

Caterson, Ian D. ;

Leibman, Steven ;

Smith, Garett S. ;

Sambrook, Philip N. ;

Fransen, Marlene ;

March, Lyn A. .

OBESITY, 2009, 17 (11) :2114-2118

[3]

[Anonymous], CLIN DIABETES MELLIT

[4] A School-Based Intervention for Diabetes Risk Reduction. [J].

Baranowski, T. ;

Adams, L. ;

Baranowski, J. ;

Canada, A. ;

Cullen, K. W. ;

Dobbins, M. H. ;

Jago, R. ;

Oceguera, A. ;

Rodriguez, A. X. ;

Speich, C. ;

Tatum, L. T. ;

Thompson, D. ;

White, M. A. ;

Williams, C. G. ;

Goldberg, L. ;

Cusimano, D. ;

DeBar, L. ;

Elliot, D. ;

Grund, H. M. ;

Kuehl, K. ;

McCormick, S. ;

Moe, E. ;

Roullet, J. B. ;

Stadler, D. ;

Foster, G. D. ;

Brown, J. ;

Creighton, B. ;

Faith, M. ;

Ford, E. G. ;

Glick, H. ;

Kumanyika, S. ;

Nachmani, J. ;

Rosen, J. ;

Rosen, L. ;

Sherman, S. ;

Solomon, S. ;

Virus, A. ;

Volpe, S. L. ;

Willi, S. ;

Cooper, D. ;

Bassin, S. ;

Bruecker, S. ;

Ford, D. ;

Galassetti, P. ;

Greenfield, S. ;

Hartstein, J. ;

Krause, M. ;

Opgrand, N. ;

Rodriguez, Y. ;

Schneider, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) :443-453

[5] The direct medical cost of type 2 diabetes [J].

Brandle, M ;

Zhou, HH ;

Smith, BRK ;

Marriott, D ;

Burke, R ;

Tabaei, BP ;

Brown, MB ;

Herman, WH .

DIABETES CARE, 2003, 26 (08) :2300-2304

[6] 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study [J].

Bray, G. A. ;

Chatellier, A. ;

Duncan, C. ;

Greenway, F. L. ;

Levy, E. ;

Ryan, D. H. ;

Polonsky, K. S. ;

Tobian, J. ;

Ehrmann, D. ;

Matulik, M. J. ;

Clark, B. ;

Czech, K. ;

DeSandre, C. ;

Hilbrich, R. ;

McNabb, W. ;

Semenske, A. R. ;

Goldstein, B. J. ;

Smith, K. A. ;

Wildman, W. ;

Pepe, C. ;

Goldberg, R. B. ;

Calles, J. ;

Ojito, J. ;

Castillo-Florez, S. ;

Florez, H. J. ;

Giannella, A. ;

Lara, O. ;

Veciana, B. ;

Haffner, S. M. ;

Montez, M. G. ;

Lorenzo, C. ;

Martinez, A. ;

Hamman, R. F. ;

Testaverde, L. ;

Bouffard, A. ;

Dabelea, D. ;

Jenkins, T. ;

Lenz, D. ;

Perreault, L. ;

Price, D. W. ;

Steinke, S. C. ;

Horton, E. S. ;

Poirier, C. S. ;

Swift, K. ;

Caballero, E. ;

Jackson, S. D. ;

Lambert, L. ;

Lawton, K. E. ;

Ledbury, S. ;

Kahn, S. E. .

LANCET, 2009, 374 (9702) :1677-1686

[7] The progressive cost of complications in type 2 diabetes mellitus [J].

Brown, JB ;

Pedula, KL ;

Bakst, AW .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1873-1880

[8] Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada [J].

Caro, JJ ;

Getsios, D ;

Caro, I ;

Klittich, WS ;

O'Brien, JA .

DIABETIC MEDICINE, 2004, 21 (11) :1229-1236

[9] Lifetime costs of complications resulting from type 2 diabetes in the US [J].

Caro, JJ ;

Ward, AJ ;

O'Brien, JA .

DIABETES CARE, 2002, 25 (03) :476-481

[10] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

LANCET, 2002, 359 (9323) :2072-2077

← 1 2 3 4 5 →